Rifamycins

All categories
DBCAT001005Pharmacologic class

A group of ANTI-BACTERIAL AGENTS characterized by a chromophoric naphthohydroquinone group spanned by an aliphatic bridge not previously found in other known ANTI-BACTERIAL AGENTS. They have been isolated from fermentation broths of Streptomyces mediterranei. A DrugBank category of 6 drugs. 5 of them are approved.

Part of
Anti-Bacterial Agents
Also known as
Rifamycin Antibiotics · Rifamycin Derivatives · Rifamycins and derivatives · Rifomycins
Drugs

What you can answer from here — as of October 27, 2022

6DrugsEach linked to its full drug card
Listed above
8Drug targetsEvery drug–target pair in the class, with bond type
Sign in
506Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
10Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Rifamycins share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In